- 2021 Press Releases
- 2020 Press Releases
- Dr. Steve Strongwater named to Modern Healthcare’s 50 Most Influential Clinical Executives
- Atrius Health Proud to Support COVID-19 Response at Boston Hope Medical Center
- Atrius Health Engages Kyruus to Advance Novel Digital Patient Access Initiatives
- Atrius Health and Firefly Health Announce Value-Based Care Affiliation
- Atrius Health’s Next Generation Accountable Care Organization Saves Medicare $14.8 million in second year of participation
- Atrius Health Welcomes Three New Clinicians to its Board of Trustees
- 2019 Press Releases
- Verily Partners with Veterans Administration Palo Alto Healthcare System and Atrius Health to Deploy Solutions for Improving Population Health and the Value of Care Delivery
- Atrius Health will be recognized as an “Allied Member” of The Permanente Federation
- Atrius Health reports $38.7M operating surplus for 2018
- Atrius Health, Blue Cross Blue Shield of Massachusetts Announce Deeper Collaboration to Transform Health Care Experience
Verily, an Alphabet company, today announced partnerships with the Veterans Administration Palo Alto Healthcare System (VAPAHCS) and Atrius Health to evaluate and deploy new tools and interventions aimed at optimizing care delivery. The partnerships leverage Verily’s deep experience in data ingestion, analytics, behavioral activation and product development to improve the value of care.
“These progressive partners are joining a growing community of health systems, accountable care organizations and government entities, who have partnered with us to research and deploy products that improve the healthcare experience for patients and providers,” said Vivian Lee MD, president of health platforms, Verily. “At Verily, we are committed to improving outcomes and reducing waste in the healthcare system. We believe that by empowering patients and providers with new engaging tools and actionable data, we are driving toward a value-based healthcare system that benefits all stakeholders.”
VA Palo Alto Healthcare System (VAPAHCS) provides comprehensive patient care services and is one of the top three research programs in Veteran Administration. VAPAHCS is collaborating with Verily to analyze and improve the value of healthcare delivered across high priority condition areas, with initial focus on total knee arthroplasty, acute myocardial infarction, and alcohol withdrawal care. The collective goal is to empower VA staff with advanced tools to increase quality and efficiency, and in the process potentially identify new opportunities for enhanced practice guidelines for VA sites across the country.
“This important collaboration provides valuable healthcare tools and expertise as part of our mission to ensure Veterans receive the best and most advanced healthcare available,” said U.S. Army Veteran and VAPAHCS Director Thomas J. Fitzgerald III. “This initiative is part of our broader commitment, through the recently launched National Center for Collaborative Healthcare Innovation, to bring cutting-edge innovation and technology to VA.”
Atrius Health, New England’s largest independent medical group and a national leader in value based care, is committed to evidence-based care and population health management that keeps patients out of the emergency department. Verily and Atrius Health will work together to analyze Atrius Health’s population health data in order to identify clinical drivers of hospitalization risk and interventions available to mitigate risk for various types of heart failure patients. The partners aim to deploy new tools that help clinicians intervene earlier and better manage patients with heart failure with the goal of reducing emergency department visits or hospitalizations.
“We look forward to collaborating with Verily to enhance the patient experience, and reduce the overall cost of care by keeping our patients healthy in their communities rather than in the hospital,” said Steve Strongwater, MD, President & CEO, Atrius Health. “This initiative will enable us to dive deep into the underlying challenges faced by our patients with heart failure and to deploy new tools and interventions that provide them the right care when they need it.”